SCHEMBL9105211

SCHEMBL9105211

CCCCCCCCOc1ccc(N(C(=O)C(=O)O)c2nc(-c3cccnc3)cs2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 7/20 0.52
ATP4B P51164 7/20 0.52
NPC1 O15118 5/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
POLB P06746 1/20 0.47
GFER P55789 1/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP19A1 P11511 1/20 0.47
RAB9A P51151 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656737 0.91 ATP4A (0.50) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL4655616 0.91 ATP4A (0.53) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL4656445 0.90 ATP4A (0.49) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL4656417 0.90 ATP4A (0.52) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL4656576 0.90 ATP4A (0.52) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL5429220 0.88 ATP4A (0.50) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL4656438 0.86 ATP4A (0.49) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL5419935 0.86 ATP4A (0.49) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL5417643 0.83 ATP4A (0.46) ATP4AATP4BNPC1NFKB1NFKB2
SCHEMBL3128282 0.81 ATP4A (0.52) ATP4AATP4BNPC1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2460800-A1 Substituted aminothiazole derivatives with anti-HCV activity Achillion Pharmaceuticals, Inc. (US) 2012-06-06 EP disclosed